Codexis Inc (CDXS) Stock Price, Quote & News

Company Profile

Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with A...

Industry: Biotechnology

Sector: Healthcare

Phone: 650 421 8100

Website: www.codexis.com

Address:

200 Penobscot Drive, Redwood City, United States

buymoremakemore Aug. 3 at 5:54 PM

$CDXS Gonna buy 12k shares tomorrow. Im bummed I didnt snag at $2.2 but $2.6s -$2.7s is still a solid entry point. This dip is a gift

0 · Reply

Fingerlickengood Aug. 1 at 5:14 PM

$CDXS $NVS Time to seal the deal with a US partnership! https://finance.yahoo.com/news/trump-unleashes-massive-tariffs-swiss-111107637.html

0 · Reply

Fingerlickengood Aug. 1 at 4:51 PM

$CDXS $NVS This is going to be a Grandslam of a partnership! https://www.patientcareonline.com/view/fda-label-update-positions-inclisiran-as-first-line-monotherapy-for-hypercholesterolemia

0 · Reply

Humble_Mozzarella Aug. 1 at 7:22 AM

$CDXS should i invest here?

2 · Reply

Humble_Mozzarella Aug. 1 at 6:58 AM

$CDXS Codexis .. how is the situation here?

1 · Reply

Jdnguyen24 Aug. 1 at 6:14 AM

$CDXS - TAILWIND🫡 https://www.cnbc.com/2025/07/31/trump-drug-prices-eli-lilly.html

1 · Reply

Leodog Jul. 31 at 4:25 PM

$CDXS

0 · Reply

Wealth_ Jul. 31 at 1:46 PM

$CDXS

0 · Reply

Bondra Jul. 29 at 3:46 PM

$TGTX $AKBA $HROW $CRMD $CDXS If i had 1 cent everytime these stocks mirrored XBI and people DOOMED and GLOOMED like there is a bad leak id be a MILLIONAIRE.

0 · Reply

PepCF Jul. 28 at 7:44 AM

$CDXS I'm a fan of Baker Bros, but Opaleye is showing better performance. I'm buying some here.

0 · Reply

Codexis to Report Second Quarter 2025 Financial Results on August 13

May 22, 2025, 7:00 AM EDT - 2 months ago

Codexis' Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA

May 21, 2025, 4:05 PM EDT - 2 months ago

Codexis to Participate in Jefferies Global Healthcare Conference

May 14, 2025, 6:50 PM EDT - 2 months ago

Codexis, Inc. (CDXS) Q1 2025 Earnings Call Transcript

May 14, 2025, 4:05 PM EDT - 2 months ago

Codexis Reports First Quarter 2025 Financial Results

May 7, 2025, 7:00 AM EDT - 3 months ago

Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting

Apr 30, 2025, 4:05 PM EDT - 3 months ago

Codexis to Report First Quarter 2025 Financial Results on May 14

Apr 9, 2025, 5:00 PM EDT - 4 months ago

Codexis Announces Byron Dorgan to Retire from Board of Directors

Mar 7, 2025, 4:05 PM EST - 5 months ago

Codexis Announces New Employment Inducement Grants

Feb 27, 2025, 10:20 PM EST - 5 months ago

Codexis, Inc. (CDXS) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 4:05 PM EST - 6 months ago

Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27th

Feb 6, 2025, 4:05 PM EST - 6 months ago

Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board

Jan 16, 2025, 4:05 PM EST - 7 months ago

Codexis Appoints Christos Richards to Board of Directors

Nov 19, 2024, 4:05 PM EST - 9 months ago

Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference

Nov 14, 2024, 4:05 PM EST - 9 months ago

Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics

Nov 12, 2024, 4:05 PM EST - 9 months ago

Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors

Nov 11, 2024, 4:05 PM EST - 9 months ago

Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics

Nov 4, 2024, 4:05 PM EST - 9 months ago

Codexis to Participate in Upcoming Healthcare Conferences

Oct 31, 2024, 10:48 PM EDT - 9 months ago

Codexis, Inc. (CDXS) Q3 2024 Earnings Call Transcript

Oct 24, 2024, 4:05 PM EDT - 10 months ago

Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting

Oct 10, 2024, 4:05 PM EDT - 10 months ago

Codexis to Report Third Quarter 2024 Financial Results on October 31

Oct 2, 2024, 4:05 PM EDT - 10 months ago

Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company

Oct 1, 2024, 7:05 AM EDT - 10 months ago

Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences

Aug 20, 2024, 4:05 PM EDT - 1 year ago

Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting

Aug 15, 2024, 4:05 PM EDT - 1 year ago

Codexis Publishes FY2023 Sustainability Disclosures

Aug 8, 2024, 11:01 PM EDT - 1 year ago

Codexis, Inc. (CDXS) Q2 2024 Earnings Call Transcript

Jul 18, 2024, 4:05 PM EDT - 1 year ago

Codexis to Report Second Quarter 2024 Financial Results on August 8

Jul 1, 2024, 4:05 PM EDT - 1 year ago

Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets

May 20, 2024, 4:05 PM EDT - 1 year ago

Codexis to Participate in TD Cowen 2nd Annual Sustainability Week

May 14, 2024, 6:00 AM EDT - 1 year ago

Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting

May 2, 2024, 8:24 PM EDT - 1 year ago

Codexis, Inc. (CDXS) Q1 2024 Earnings Call Transcript

Apr 18, 2024, 4:05 PM EDT - 1 year ago

Codexis to Report First Quarter 2024 Financial Results on May 2

Apr 11, 2024, 7:05 AM EDT - 1 year ago

Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board

Feb 28, 2024, 10:39 PM EST - 1 year ago

Codexis, Inc. (CDXS) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 4:05 PM EST - 1 year ago

Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Feb 26, 2024, 4:05 PM EST - 1 year ago

Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche

Feb 26, 2024, 8:05 AM EST - 1 year ago

Codexis to Participate in TD Cowen 44th Annual Health Care Conference

Feb 20, 2024, 8:05 AM EST - 1 year ago

Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board

Feb 14, 2024, 4:05 PM EST - 1 year ago

Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28

Feb 13, 2024, 4:05 PM EST - 1 year ago

Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones

Feb 1, 2024, 4:05 PM EST - 1 year ago

seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting

Dec 27, 2023, 8:30 AM EST - 1 year ago

Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108

Dec 13, 2023, 4:06 PM EST - 1 year ago

Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

Dec 13, 2023, 4:05 PM EST - 1 year ago

Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform

Dec 11, 2023, 7:05 AM EST - 1 year ago

Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeutics Manufacturing

Nov 28, 2023, 4:05 PM EST - 1 year ago

Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics Manufacturing on December 8, 2023

Nov 14, 2023, 4:05 PM EST - 1 year ago

Codexis to Participate in 35th Annual Piper Sandler Healthcare Conference

Nov 2, 2023, 9:32 PM EDT - 1 year ago

Codexis, Inc. (CDXS) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 4:05 PM EDT - 1 year ago

Codexis Reports Third Quarter 2023 Financial Results

Oct 27, 2023, 3:35 PM EDT - 1 year ago

Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe

buymoremakemore Aug. 3 at 5:54 PM

$CDXS Gonna buy 12k shares tomorrow. Im bummed I didnt snag at $2.2 but $2.6s -$2.7s is still a solid entry point. This dip is a gift

0 · Reply

Fingerlickengood Aug. 1 at 5:14 PM

$CDXS $NVS Time to seal the deal with a US partnership! https://finance.yahoo.com/news/trump-unleashes-massive-tariffs-swiss-111107637.html

0 · Reply

Fingerlickengood Aug. 1 at 4:51 PM

$CDXS $NVS This is going to be a Grandslam of a partnership! https://www.patientcareonline.com/view/fda-label-update-positions-inclisiran-as-first-line-monotherapy-for-hypercholesterolemia

0 · Reply

Humble_Mozzarella Aug. 1 at 7:22 AM

$CDXS should i invest here?

2 · Reply

Humble_Mozzarella Aug. 1 at 6:58 AM

$CDXS Codexis .. how is the situation here?

1 · Reply

Jdnguyen24 Aug. 1 at 6:14 AM

$CDXS - TAILWIND🫡 https://www.cnbc.com/2025/07/31/trump-drug-prices-eli-lilly.html

1 · Reply

Leodog Jul. 31 at 4:25 PM

$CDXS

0 · Reply

Wealth_ Jul. 31 at 1:46 PM

$CDXS

0 · Reply

Bondra Jul. 29 at 3:46 PM

$TGTX $AKBA $HROW $CRMD $CDXS If i had 1 cent everytime these stocks mirrored XBI and people DOOMED and GLOOMED like there is a bad leak id be a MILLIONAIRE.

0 · Reply

PepCF Jul. 28 at 7:44 AM

$CDXS I'm a fan of Baker Bros, but Opaleye is showing better performance. I'm buying some here.

0 · Reply

Levis6 Jul. 25 at 5:53 PM

$CDXS

0 · Reply

Fingerlickengood Jul. 25 at 5:12 PM

$CDXS $NVO $ALNY https://www.bachem.com/articles/news/bachem-novo-nordisk-redesign-spps-for-green-chemistry/

0 · Reply

Fingerlickengood Jul. 25 at 4:57 PM

$CDXS $BCHMF $NVO $ALNY This is starting to add up.... https://www.bachem.com/articles/news/bachem-novo-nordisk-redesign-spps-for-green-chemistry/

0 · Reply

Fingerlickengood Jul. 25 at 2:52 PM

$CDXS $NVO $ALNY Interesting! https://informaconnect.com/rna-leaders-usa/speakers/alison-moore/

0 · Reply

Fingerlickengood Jul. 25 at 1:42 PM

$CDXS $BCHMF We are definitely in good company! https://www.koreabiomed.com/news/articleView.html?idxno=28359

0 · Reply

Fingerlickengood Jul. 24 at 1:06 PM

$CDXS $BCHMF "The Bachem Group (SIX: BANB) achieved sales of CHF 313.0 million in the first half of 2025 (+30.2% compared to the prior-year period: CHF 240.3 million). In local currencies (LC), sales increased by 34.1%." Great partner to have! https://www.newsfilecorp.com/release/259916/Bachem-Shows-Strong-Growth-in-the-First-Half-of-2025

0 · Reply

Fingerlickengood Jul. 24 at 1:04 PM

$CDXS $BCHMF "a scale-up of manufacturing needs is expected in the medium term, which again favors suppliers who can offer innovative solutions for more efficient production." Who does that sound like?! https://www.bachem.com/about-bachem/investors-and-media/reports-and-presentations/

0 · Reply

form4ai Jul. 23 at 5:06 PM

$CDXS join form4.ai and get real-time notifications on your phone whenever a form4 insider is filed.

0 · Reply

Fingerlickengood Jul. 23 at 2:29 PM

$CDXS $BCHMF This might be worth tuning into tomorrow... https://us06web.zoom.us/webinar/register/WN_OXMTQe3bRjKmtABLZ72Zyg#/registration

0 · Reply

Fingerlickengood Jul. 23 at 1:43 PM

$CDXS $NVS $MRK $AZN

0 · Reply

TheHowlingMadness Jul. 23 at 1:31 PM

$CDXS here we go

0 · Reply

Fingerlickengood Jul. 23 at 1:25 PM

$CDXS https://www.businesskorea.co.kr/news/articleView.html?idxno=247818

0 · Reply

Market Cap	222.85M
Revenue (ttm)	59.35M
Net Income (ttm)	-65.28M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-109.99%
Debt to Equity Ratio	0.59

Volume	780,700
Avg Vol	962,268
Day's Range	N/A - N/A
Shares Out	82.85M
Stochastic %K	14%
Beta	2.54
Analysts	Strong Sell
Price Target	$7.08